Catalyst
Slingshot members are tracking this event:
Johnson & Johnson (JNJ) subsidiary Janssen submits pair of FDA applications for Simponi Aria in treating active psoriatic arthritis and active ankylosing spondylitis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 21, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ankylosing Spondylitis, Simponi Aria, Janssen
